
Full FDA approval for COVID-19 vaccines could ease vaccine hesitancy: expert
Fox News
How COVID-19 vaccines can win FDA approval as the delta variant surges
The FDA granted the application priority review, and will weigh full approval for the vaccine in people 16 and up by January, though a spokesperson at the FDA told Fox News last week the agency expects to complete the review "far in advance" of the January target date. The application approval could pave the way for the official approval of the other two vaccines, Moderna, which filed its application last month, and Johnson & Johnson. More than 182.7 million people in the U.S. (more than half of the total population) have received at least one dose of the COVID-19 vaccine, according to the Centers for Disease Control and Prevention (CDC), since the FDA granted emergency use authorization in December. And the urgency to get more Americans vaccinated comes as the delta variant of coronavirus cases continues to rise across the country. Pfizer, Moderna and Johnson & Johnson all received their EUA, which mandated that the companies follow a set of guidelines calling for safety data from clinical trials and information on its quality and consistency, according to ScienceMag.org.More Related News